|
⚲
|
| DAFNA Capital Management LLC
✚
|
|
|---|---|
| CRD # | 129053 |
| SEC # | 801-62559 |
| CIK # | 0001389933 |
| AUM | $542.7 MM (2023-03-30) |
| Employees | 7 (86% Investors, 0% Brokers) |
| Phone | 310-954-3200 |
| Address | 10990 Wilshire Boulevard Los Angeles, CA 90024 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] |
| Total AUM ($MM) |
|---|
| CIK | Period |
|---|---|
| 0001389933 | |
| / | |
| Sector | Form 13F Holdings | Cap ($MM) | Value ($MM) |
|---|---|---|---|
| Stereotaxis Inc | 135.9 | 27.9 | |
| Ophthotech Corp | 1,109.5 | 14.9 | |
| Ascendis Pharma A/S | 5,198.1 | 14.5 | |
| Karuna Therapeutics Inc | 3,605.4 | 14.3 | |
| Revolution Medicines Inc | 1,299.3 | 12.5 | |
| Blueprint Medicines Corp | 3,184.6 | 11.8 | |
| Xenon Pharmaceuticals Inc | 1,599.0 | 11.3 | |
| Cytokinetics Inc | 4,051.3 | 9.7 | |
| Syndax Pharmaceuticals Inc | 1,042.0 | 9.4 | |
| Dexcom Inc | 29,320.0 | 7.8 | |
| Sage Therapeutics Inc | 1,922.0 | 7.6 | |
| Neurocrine Biosciences Inc | 9,264.2 | 7.6 | |
| Morphic Holding Inc | 812.1 | 6.8 | |
| IDEAYA Biosciences Inc | 505.8 | 6.4 | |
| DICE Therapeutics Inc | 585.3 | 5.4 | |
| Viking Therapeutics Inc | 209.7 | 5.3 | |
| Merus NV | 941.6 | 5.2 | |
| AtriCure Inc | 1,835.8 | 5.2 | |
| Nurix Therapeutics Inc | 521.4 | 5.0 | |
| Edgewise Therapeutics Inc | 385.2 | 4.9 | |
| Carbylan Therapeutics Inc | 236.1 | 4.8 | |
| Biocryst Pharmaceuticals Inc | 1,941.2 | 4.6 | |
| Restorbio Inc | 274.3 | 4.6 | |
| Century Therapeutics Inc | 479.6 | 4.5 | |
| Apellis Pharmaceuticals Inc | 4,727.4 | 3.8 | |
| Alector Inc | 832.3 | 3.7 | |
| Accuray Inc | 185.6 | 3.6 | |
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| HF | DAFNA Fund LP Series A | [2012-03-29] | 278.8 | 215.2 |
| HF | DAFNA Fund LP Series B | [2012-03-29] | 278.8 | 0.5 |
| HF | DAFNA Fund LP Series C | [2012-03-29] | 278.8 | 108.1 |
| HF | DAFNA International Fund Ltd Class A | 2012-03-29 | 189.5 | |
| HF | DAFNA International Fund Ltd Class B | 2012-03-29 | 0.0 | |
| HF | DAFNA International Fund Ltd Class C | 2012-03-29 | 27.6 | |
| HF | DAFNA Lifescience LP | 2012-03-29 | 406.8 | |
| HF | DAFNA Lifescience Market Neutral LP | 2012-03-29 | 0.5 | |
| HF | DAFNA Lifescience Select LP | 2012-03-29 | 135.9 |
| AUM Breakdown | Accounts | AUM ($MM) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 4 | 542.7 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 4 | 542.7 |
| By Discretionary | ||
| Discretionary | 4 | 542.7 |
| Non-Discretionary | 0 | 0.0 |
| Total | 4 | 542.7 |
| By Non-United States Persons | ||
| Non-United States Persons | 217.1 | |
| United States Persons | 325.7 | |
| Total | 4 | 542.7 |
| Form D Directors | # Filings | # Firms | 2011 - 2024 |
|---|---|---|---|
| Nathan Fischel | 2 | ||
| Fariba Ghodsian | 1 |
| EDGAR Form | CIK | 2011 - 2024 |
|---|---|---|
| 13F-HR | [0001389933] | |
| 3 | [0001389933] | |
| SC 13D | [0001389933] | |
| SC 13G | [0001389933] |
| Form 3/4/5 Subject | 2011 - 2024 |
|---|---|
| Ghodsian Fariba Fischel | |
| DAFNA Capital Management LLC | |
| Stereotaxis, Inc. |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
Keenan Capital LLC
✚
|
CA | 0.6 |
|
Riva Ridge Capital Management LP
✚
|
NY | 0.5 |
|
Fort LP
✚
|
MD | 0.5 |
|
Silvermine Capital Management LLC
✚
|
NY | 0.5 |
|
Engle Capital Management LP
✚
|
CT | 0.5 |
|
Logan Stone Capital LLC
✚
|
IL | 0.5 |
|
Oribel Capital Management LP
✚
|
NY | 0.5 |
|
Solas Capital Management LLC
✚
|
CT | 0.5 |
|
Otus Capital Management Limited
✚
|
0.5 | |
|
Truffle Hound Capital LLC
✚
|
MD | 0.5 |